Trying to Keep Up
with Michael Nilo & Allison Komiyama
A weekly live call where two regulatory nerds talk about what's actually happening at the FDA's CDRH and how it's affecting real teams, real timelines, and real decisions
A weekly live call where two regulatory nerds talk about what's actually happening at the FDA's CDRH and how it's affecting real teams, real timelines, and real decisions

The team breaks down major FDA De Novos, PMAs, breakthrough devices, and melanoma reclassification updates—including sleep apnea tech, heart valves, home diagnostics, and the future of medtech innovation.

Aubrey Shick joins to break down how the FDA is approaching generative AI, what TEMPO submissions reveal about evolving policy, and why digital health still lives in regulatory gray zones.

FDA hiring, AI imaging surprises, and real-world orthopedic innovation—plus insights from former FDA leader Melissa Hall on navigating today’s regulatory landscape.

A former FDA reviewer shares what really happened during mass layoffs—plus De Novo updates, a new PMA approval, and what AI changes could mean for MedTech.